The
ebola pandemic began in late February in the former French colony of Guinea
while UN agencies were conducting nationwide vaccine campaigns for three
other diseases in rural districts. The simultaneous eruptions of this
filovirus virus in widely separated zones strongly suggests that the virulent
Zaire ebola strain (ZEBOV) was deliberately introduced to test an antidote
in secret trials on unsuspecting humans.

The cross-border escape of ebola into neighboring Sierra Leone and Liberia
indicates something went terribly wrong during the illegal clinical trials
by a major pharmaceutical company. Through the lens darkly, the release
of ebola may well have been an act of biowarfare in the post-colonial
struggle to control mineral-rich West Africa

Earlier this year, rural residents eagerly stood in line to receive vaccinations
from foreign-funded medical programs. Since the cover-up of the initial
outbreak, however, panicked West Africans rural folk are terrified of
any treatment from international aid programs for fear of a rumored genocide
campaign. The mass hysteria is also fueled in a region traditionally targeted
by Western pedophiles by the fact that filovirus survives longer in semen
than in other body fluids, a point that resulted in murderous attacks
on young men believed to be homosexuals. Ebola detonated fear and
loathing, and perhaps that is exactly the intended objective of a destabilization
strategy.

This ongoing series of investigative journalism reports on the ebola crisis
exposes how West Africans are largely justified in their distrust of the
Western aid agencies that unleashed, whether by mistake or deliberate
intent, the most virulent virus known to man.

Guilt Without Doubt

A pair of earlier articles by this writer examined the British and American
roles in developing ebola into a biological weapon and its antidotes into
commercial products. This third essay examines the strange coincidence
of the earliest breakout in Guinea with three major vaccine campaigns
conducted by the World Health Organization (WHO) and the UN children’s
agency UNICEF. At least two of the vaccination programs were implemented
by Medicins Sans Frontieres (MSF, or Doctors Without Borders), while some
of those vaccines were produced by Sanofi Pasteur, a French pharmaceutical
whose major shareholder is the Rothschild Group. This report uncovers
the French connection to the African ebola pandemic.

Human Guinea Pigs

The guinea pig used in laboratory testing of new drugs is neither a pig
nor from Guinea, since its natural habitat is on another continent, specifically
the Andes. The test subjects at the time of the very first ebola outbreaks
in Guinea were not rodents or pigs; they were humans.

The mystery at the heart of the ebola outbreak is how the 1995 Zaire (ZEBOV)
strain, which originated in Central Africa some 4,000 km to the east in
Congolese (Zairean) provinces of Central Africa, managed to suddenly resurface
now a decade later in Guinea, West Africa. Since no evidence of ebola
infections in transit has been detected at airports, ports or highways,
the initial infections must have come from one of either two alternative
routes:

- First, the possibility of an anonymous “Patient A”, a survivor of the
devastating 1995 Zaire pandemic, perhaps a doctor or medical worker who
was a carrier of the dormant virus into Guinea. An example of a Patient
A is Patrick Sawyer, the infected American resident of Liberia who first
transmitted ebola to Nigeria. No attempt has been made by the national
health ministry or international agencies to trace and identify the original
ebola case in Guinea. So far, not a shred of evidence has surfaced to
indicate&nbs p;the very first victim to be a foreigner or a Guinean
who had traveled abroad.

- Second, the absence of a Patient A leaves the prospect of an unauthorized
test in humans of a new antidote for ebola in rural Guinea, done under
the cover of a vaccination program for another disease. Whether the covert
clinical trial’s purpose was civilian health or military use of an antibody-based
antidote cannot be determined as of yet.

The reason for suspecting a vaccine campaign rather than an individual
carrier is due to the fact that the ebola contagion did not start at a
single geographic center and then spread outward along the roads. Instead.
simultaneous outbreaks of multiple cases occurred in widely separated
parts of rural Guinea, indicating a highly organized effort to infect
residents in different locations in the same time-frame.

The ebola outbreak in early March coincided with three separate vaccination
campaigns countrywide: a cholera oral vaccine effort by Medicins Sans
Frontieres under the WHO; and UNICEF-funded prevention programs against
meningitis and polio:

- The MSF-WHO project administered the anti-cholera vaccine Shanchol.
The drug producer Shanta Biotechnics in Hyderabad, India, is a wholly
owned subsidiary of Sanofi Pasteur based in Lyon, France. Formerly known
as Sanofi Aventis, the pharmaceutical controlled by major shareholders
L’Oreal and the Rothschild Group.

- The oral polio vaccine (OPV) drive funded by UNICEF was based on a pathogen
seed strain developed by Sanofi Pasteur, which operates the world’s largest
polio vaccine production facility.

- The meningitis vaccine MenAfrVac, was produced by the Serum Institute
of India, owned by tycoon Cyrus Poonawalla, under development funding
from the Bill and Melinda Gates Foundation. In 2013, a UNICEF drive in
Chad with the same drug resulted in 40 child deaths from vaccine-linked
symptom. MSF participated in the West African anti-meningitis project.

Medicins Sanofi Frontieres

While focused on the French role, it would be unjust not to shed light
on the American chief of the UN children’s agency. UNICEF executive directory
Anthony Lake has an ideal career background for the post of protector
of children worldwide. Tony Lake was National Security Advisor to President
Bill Clinton responsible for US military interventions, including: the
Bosnia-Herzegovina war against the Yugoslav federation; the Battle of
Mogadishu in Somalia better known as “Blackhawk Down”; and Operation Uphold
Democracy in Haiti. An ardent& nbsp;Zionist convert to Judaism, he
is the perfect boss to dispense risky vaccines in Muslim-majority Guinea.

One of Lake’s closest international allies during the Balkans war, who
shares his policy of “expansionist democracy” and “humanitarian intervention”
is French-Jewish hero Bernard Kouchner. The co-founder of Medicins Sans
Frontier, the leftist politician-doctor was appointed Foreign Minister
under neoconservative President Nicholas Sarkozy. Before succumbing to
the temptation of shouting “Physician heal thyself!”, let’s turn back
to tracking ebola.

MSF, which translates into English as Doctors Without Borders, promotes
itself as a brave band of selfless physicians who spend their time and
own savings on helping the poor in global hot spots. Many of the volunteers,
to their individual credit and moral goodness, actually exemplify the
public-relations image, never realizing that MSF corporate sponsors include
the Bill Gates-founded behemoth Microsoft, Goldman Sachs, AIG, Morgan
Stanley, Bank of America, BlackRock, Bloomberg and the French advertising
giant Havas.

A rogue’s gallery of corporate predators, if ever there was, the donor
list is notably absent of major pharmaceuticals, since it would
be a conflict of interest to charitably dispense vaccines from a drug
company while being paid for the free advertising. To avoid appearances
of ethical impropriety on a global scale, the UN through its agencies
WHO and UNICEF foots the bill, the major pharms get the profits, and MSF
executives with their horde of bright-eyed volunteers dispense the low-end
vaccines on the suffering mass es.

Not to discourage idealist doctors from a worthy cause, there is the undeniable
attraction of safari fever and Orientalist exoticism for a surgeon from
Pittsburg or Strasbourg to take part in this hybrid of “Amazing Race”
and Club Med. Now off with the kid gloves: While posturing as principled
ethical “witnesses” to human misery, the functional role of MSF role is
as a conveyor belt dumping vaccines from major pharmaceuticals onto low-income
and poorly educated populations of the developing world.

Repeated dosages of potent toxins on populations with poor health, which
no public-health agency in the Western world dares attempt inside its
own borders, can have harmful side effects, especially on children. The
casualties of vaccination have gone unreported by the media and buried
under official cover-ups. Even worse, vaccine programs could well have
been used to conceal human testing of antibodies that originated in biological
warfare labs for the purpose of mass murder of entire nations.

Best Laid Plans

Doctors Without Frontiers (MSF), once based in Paris and now in Geneva,
comes under a dark cloud of suspicion because its distribution of a two-step
anti-cholera vaccine. The dosages must be taken a fortnight apart, and
this repeat procedure likely provided the pretext for an ebola-testing
team to insert the ebola virus into the victims’ bodies and later return
to dispense the antidote of monoclonal antibodies (Mab).

(This is not to say that MSF was knowingly involved as an organization
but that its “federation” style of management leaves a lot of maneuvering
space for an unethical doctor to infiltrate a country program on behalf
a client pharmaceutical.)

After exposure to the ebola virus, a patient shows symptoms of high fever,
vomiting and diarrhea, no less than 8 days later and likelier after two
weeks. Re-arriving on schedule, the covert drug-testing team administers
the anti-ebola antibodies as “the second dose of cholera vaccine”. The
perfect crime of illegal human testing should have gone off without a
hitch.

A problem arises, however, when many of the test subjects fall sick in
less than two weeks and are unable to walk dozens of kilometers to the
vaccine centers. With much of the original cohort of human test subjects
absent for the antidote, and ebola out of control in the hinterland, the
secret clinical trial free-falls toward a pit of liability and legal action.
Disappointed operations managers for the sponsoring pharmaceutical order
the exfiltration of their medical agents out of Guinea, leaving hundreds
of victims to die in excruciating pain as the contagion spreads.
Does anyone in Paris or Geneva really care? Don’t choke in laughter.

The Guinea outbreak was not reported by WHO until 6 weeks after the initial
round of infections in February, which is quite odd considering the armies
of medical workers afield in the countryside during those three vaccine
campaigns. By contrast, the MSF office in next-door Senegal knew about
the Guinean ebola contagion less than a month after outbreak.

Inside and Outside the Death Zones

On the map of Africa, the Republic of Guinea (not to be confused with
Equatorial Guinea on the coast of Central Africa) is shaped like a reversed
letter C, looping off the Atlantic shore and curving southeast into the
interior. The Niger River cuts across the country from east to west; two
separate regions along its banks were the centers of the initial ebola
outbreak.

The earliest infections were concentrated in the inland prefectures of
Guecedo and Macenta on the interior borders of Sierra Leone and Liberia.
The second-most affected region was closer to the Atlantic coast in the
districts of Boffa and Telimele and the nearby island-capital of Conakry.
The deaths in Conakry were concentrated at Donka Hospital, the prime treatment
center.

What is striking about the Red Cross-Red Crescent Society map of the outbreak
zones was the lack of infections over a wide swath along the border with
Senegal, where MSF keeps its regional headquarters with a 300-member staff,
which includes 80 foreigners. The reason can be attributed to the drier
climate of Senegal, yet to the contrary ebola infections were reported
near Guinea’s northern border with arid Mali, which is in the Sahara Desert.

On first reports of the outbreak, the Pasteur Institute branch in Dakar,
Senegal, dispatched a mobile microbiology laboratory to Conakry at the
request of the Guinean Ministry of Health. Meanwhile, the German-funded
Bernhard-Nocht Institute of Tropical Medicine office in Ghana cooperated
with WHO to set up a mobile lab in Gueckedou Prefecture.

MSF staffers inside Guinea cooperated with the government’s Ministry of
Health effort to set up isolation rooms in local clinics and hospitals
along with blood-sample collection centers. Despite assurances from WHO
and CDC that ebola is not transmitted through water or air, more than
100 nurses and doctors, including Sierra Leone’s top ebola expert, have
died so far. Misinformation about ebola transmission is inexcusable when
the 1995 Zaire outbreak was first spread by the washing of corpses.

Turning Panic Into Profit

Another appalling surprise came in June with the “second wave” of apparently
more virulent ebola infections across Sierra Leone, even after the pandemic
was coming under control in Guinea. This second breakout could be related
to a mutation caused by the introduction of monoclonal antibodies during
the covert antidote tests. Confronted by Mab-activated immune responses
in humans, the virus could be expected to adapt by increasing the velocity
of its docking with unprotected human blood cells. If mutation is confirmed,
then all Mab-based&n bsp;serums should be banned due to the potential
emergence of the unstoppable “super-virus”, a modified strain of ebola
on steroids.

News media have focused on two potential cures for ebola issued by biotech
companies ZMapp and Tekmira, both of them essentially business fronts
for patent-sharing consortia. Whichever company gains approval from an
FDA, ready to overlook the possibility of driving mutations, will be sure
to win huge supplier contracts from the WHO and the US Department of Defense.

The dark horse in the foot race to profit from the ebola panic is France-based
Sanofi Pasteur. The world’s third-largest pharmaceutical, under CEO Serge
Weinberg, has earned a reputation for come-from-behind success in the
final rounds of clinical trials in humans. Weinberg scored a coup in wooing
his new chief scientist Gary Nabel from his position as head of viral
immunology research at the National Institutes of Health (NIH).

The Sanofi strategy for ebola is being kept under wraps by its biotech
partner Sutro Biopharma based in San Francisco. Sutro managing director
John Freund, MD, is a former Morgan Stanley executive who built its health-care
portfolio. The Sutro-Sanofi-Nabel monoclonal antibody (Mab) strategy,
using tumor antigen Mabs, is listed for purposes “undisclosed”. The use
of antibodies from abnormal or cancerous cells is the same as the cell-fusion
method used by their now better-known competitor ZMapp.

For the unethical executive, it is tempting to conduct drug tests in humans
without wasting years on monkey trials, as was done by wartime Japan’s
Unit 731 and by Dr. Joseph Mengele. In 2008, Sanofi was accused of conducting
secret trials of an untested H5N1 vaccine on 350 homeless people in Poland,
killing at least 21 and causing the hospitalization of 200 others, according
to the Telegraph of London.

The cold-blooded spread of a hemorrhagic fever cannot be attributed solely
to corporate greed, since biodefense security is also a motive. The West
African outbreak was likely linked to a dual-use experiment, for application
in tropical health and as a biowarfare shield, as shown in the two earlier
essays in this series.

On the List of Suspects

While a signatory of the Biological Weapons Convention, France did not
sign aboard until 1984, providing sufficient time to guise its biowarfare
research under civilian lab coats. The nation that produced brilliant
scientists like Louis Pasteur, the pioneer discoverer of vaccines, France
was one of the leading research centers in biological warfare, weaponizing
anthrax, salmonella, chorela and rindepest, toxins that resonate with
the French passion for cuisine.

The postwar French military had none of the ability to commandeer Germany’s
formidable bioweapons technology, as did Britain, the US and Soviet Union.
Instead of focusing on the German passion for “germ” warfare, French medical
researchers skipped ahead by concentrating on molecular biology, in which
viruses are of intense interest for their interactions with the proteins
in cell membranes and nucleic acids. Due to their high-tech sophistication,
it is rare for French research centers to be caught red-handed, as happened
when the Pasteu r Institute in Iran was discovered to be crafting aflatoxin
for the Shah’s military.

French biologists moreover have had deep experience in tropical pathogens
from their own African colonies and the Belgian Congo. The nation’s most
notable achievement in recent years was Luc Montagnier’s isolation of
the HIV, which notably he claims was not of African origin, indicating
the Pasteur Institute’s vast library of biological agents.

The French are masters of ambiguity and dissimulation, and so there is
no chance for a French military attache to be seen strutting around Guinea
or Sierra Leone like a Jean Reno. The CDC in Liberia, in contrast, with
its 50-member forward squad marching in protective gear stands out like
a sore thumb.

Therefore, don’t forget to put the Elysee Palace on the suspect list if
ebola is found out to be a biowarfare attack to destabilize West Africa
and redraw the geopolitical boundaries. The French Army is largest foreign
force on the continent. To borrow Churchill’s metaphor of nesting dolls,
antibodies are a riddle wrapped in the mystery of ebola inside an enigma
of biological warfare.

The other Sanofi project in Guinea involving a polio vaccine campaign
could have enabled the follow-up work of checking on the success rate
of the secret antibody tests. If so, it was a miserable failure or perhaps
a wild success. In either case, the pharmaceutical and biotech industries
will have profited handsomely from the ebola crisis when biodefense-research
generals, high civil servants and UN bureaucrats sheepishly sign multimillion-euro
R&D contracts.
Feverish Africa

After rural West Africans realized that vaccination programs coincided
with the outbreak of Zaire ebola, foreign-funded medical staffers were
assaulted by angry mobs and an ebola treatment center in Sierra Leone
was burned to the ground. When medicine is exposed to be the problem and
not a solution, the military has to be called in to quell public rebellion.
The boundaries of every country in the region are now sealed by troops,
and so the truth behind this epidemic will probably be buried with the
victims.

As for MSF, UNICEF, WHO, CDC, NIH, USAMRIID and the rest of the alphabet
soup of the hypocritical oafs of pharmaco-witchcraft, the herd instinct
for self-preservation prevents any honest disclosure. As each day passes
and casualties mount, the onus for the crime weighs heavier. A trustworthy
investigation into this fast-spreading pandemic and prosecution of the
perpetrators in a court of law have all the chances of snowfall in Zaire.

Yoichi Shimatsu, a Thailand-based science writer, organized public-health
seminars by leading microbiologists and herbalists during the SARS outbreak
in Hong Kong and the avian influenza crisis across Southeast Asia.